image
Verve Therapeutics, Inc. VERV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.79
-11 %
$ 406 M
Market Cap
-1.95
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 505.77% -27.12% -34.67%
Annual Report FY 10-K 2022-12-31 0.00% -32.66% -90.30%
Annual Report FY 10-K 2021-12-31 0.00% -160.50% -114.31%
Annual Report FY 10-K 2020-12-31 0.00% -139.46% -197.81%
Annual Report FY 10-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 120.24% -9.56% -8.74%
Quarterly Report Q2 8-K 2024-06-30 219.73% 7.74% -0.44%
Quarterly Report Q1 8-K 2024-03-31 305.63% -6.66% 2.43%
Quarterly Report Q4 8-K 2023-12-31 408.30% -17.69% -13.07%
Quarterly Report Q3 8-K 2023-09-30 235.52% 1.64% -19.32%
Quarterly Report Q2 8-K 2023-06-30 0.00% -35.98% -38.85%
Quarterly Report Q1 8-K 2023-03-31 0.00% -60.84% -82.49%
Quarterly Report Q4 8-K 2022-12-31 0.00% -31.11% -46.62%
Quarterly Report Q3 8-K 2022-09-30 0.00% -104.49% -86.62%
Quarterly Report Q2 8-K 2022-06-30 0.00% 25.04% -148.71%
Quarterly Report Q1 8-K 2022-03-31 0.00% -114.18% -127.05%
Quarterly Report Q4 8-K 2021-12-31 0.00% -33.17% -84.89%
Quarterly Report Q3 8-K 2021-09-30 0.00% -153.05% -161.95%
Quarterly Report Q2 8-K 2021-06-30 0.00% -598.75% -153.72%
Quarterly Report Q1 8-K 2021-03-31 0.00% -136.71% -90.81%
Quarterly Report Q4 8-K 2020-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2020-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2020-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2020-03-31 0.00% 0.00% 0.00%